Playing the macro..From a weekly perspective, surprisingly, AGE finished flat at 3.9. Volume usual. So not a bad play on a very grim U week..So what is happening? To me it seems to be playing the macro. And U macro is playing weak. There was a good announcement, but U macro currently is overpowering any individual stock news. So we go with the flow. Overall U macro is playing weak. As I wrote last week, CCJ needs to hold 39A/40 level. It lost that this week. The final number is around 35. If it loses that, long winter for U stocks. AGE held the lower level of 3.8, a dip to 3.7, but not wanting to give way, yet..Personally as I wrote last week, my AGE average was 3.55. No trades for me this week. AGE held well, which meant I added other U stocks..So what may happen next week? All depends on U macro. All depends on CCJ. We don't know. Overall U macro is not bad. But a lot more people have to believe it. CCJ has to get over 40. Spot price above 80. Let's hope it plays out that way. Enjoy your weekend and all the best.
- Forums
- ASX - By Stock
- AGE WEEKLY REPORT
Playing the macro..From a weekly perspective, surprisingly, AGE...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGE (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $166.5M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 4.1¢ | $418.2K | 9.920M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 698803 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 947899 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 698803 | 0.042 |
12 | 1757310 | 0.041 |
17 | 3835509 | 0.040 |
6 | 2673708 | 0.039 |
4 | 1470000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 880844 | 4 |
0.044 | 844725 | 5 |
0.045 | 1244270 | 8 |
0.046 | 1798964 | 6 |
0.047 | 730929 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AGE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online